Chronic GVHD (cGVHD) complicating allo-SCT commonly presents as sclerotic skin changes resembling systemic sclerosis (SSc), suggesting a common pathophysiological pathway. Damage to capillaries is considered an early event in the pathogenesis of SSc, and is associated with characteristic nailfold capillary abnormalities. Whether such nailfold capillary abnormalities occur in sclerodermatous cGVHD is unknown. Nailfold videocapillaroscopy (NVC) was used to evaluate capillary morphology, density and loop dimensions in 14 patients with sclerodermatous cGVHD, 14 sex-and age-matched SSc patients, and 14 healthy controls. It was shown that none of the cGVHD patients and controls, whereas all SSc patients showed severe capillary abnormalities. cGVHD patients and controls showed no differences in capillary density (9.05 vs 9.16 loops/mm, respectively, P ¼ 0.84), and capillary loop dimensions (total loop width 44.36 vs 45.56 mm, respectively, P ¼ 0.84). Compared with cGVHD patients, SSc patients had a reduced capillary density (9.05 vs 5.25 loops/mm, respectively, Po0.001), and an increase in capillary loop dimensions (total loop width 44.36 vs 99.97 mm, respectively, P ¼ o0.001). In conclusion sclerodermatous cGVHD patients do not show the characteristic microvascular abnormalities seen in SSc, suggesting that capillary damage does not contribute to the pathophysiology of sclerodermatous cGVHD, and making NVC unsuitable for early identification.
INTRODUCTION
Chronic GVHD (cGVHD) is one of the most severe complications of allo-SCT and commonly affects the skin.
1,2 Sclerotic-type cGVHD of the skin is histologically characterised by inflammation and progressive fibrosis of the dermis and s.c. tissues, which macroscopically resembles morphea and systemic sclerosis (SSc). 3 Therefore, it has been suggested that cGVHD and SSc share aetiological mechanisms. [4] [5] [6] [7] Some investigators even postulated that SSc is a variant of cGVHD. 8 Most current hypotheses on the pathogenesis of sclerotic skin changes in SSc and cGVHD focus on the complex interplay between immunological events and vascular changes, resulting in the generation of a population of activated fibrogenic fibroblasts. 9 In both SSc and cGVHD patients with sclerotic skin changes, stimulatory autoantibodies to the PDGF receptor have been reported. 10, 11 Endothelial damage leading to microvascular changes and subsequent ischaemia-driven dermal fibrosis is another postulated mechanism that may be shared by both disorders. The precise cause of endothelial damage is unknown, although in cGVHD it is thought to be initiated by alloreactive cytotoxic T cells, 12 probably facilitated by radiation therapy. 1 Treatment of sclerotic skin changes in cGVHD may consist of corticosteroids, phototherapy with ultraviolet radiation and newer treatment modalities such as biologicals (for example, imatinib and rituximab).
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In SSc, the endothelial damage is associated with characteristic microvascular changes that can easily be visualised by using a non-invasive method like nailfold capillaroscopy. Changes that may be observed in SSc are widening (enlarged and giant capillaries), drop-out of capillaries (reduced capillary density or rarefaction) and disorganisation of the capillary architecture. [14] [15] [16] Presently, abnormal capillaroscopy is not only considered a diagnostic criterion for the very early diagnosis of SSc, 17 but also provides prognostic clinical information as it is linked to important microvascular complications in SSc. [18] [19] [20] [21] Microvascular injury is an early event and generally precedes fibrosis in SSc, 15, 22, 23 and in cGVHD patients early detection of capillary abnormalities by a non-invasive method might identify those at risk of sclerodermatous development. Whether microvascular changes that can be visualised in SSc are also present in sclerodermatous cGVHD remains to be demonstrated. Two recent studies using capillaroscopy to investigate capillary changes in sclerotic-type cGVHD showed conflicting results. 24, 25 However, neither study included SSc patients and healthy controls.
The aim of this study, therefore, was to investigate nailfold microvascular changes by using a validated method 26 of NVC in patients with sclerotic-type cGVHD, and in age-and sex-matched SSc patients and healthy controls.
PATIENTS AND METHODS Patients
Fourteen patients affected by sclerodermatous cGVHD following allo-HSCT were included in this study as were 14 age-and sex-matched SSc patients and healthy controls. The clinical diagnosis and scoring of sclerotic-type cGVHD was established as previously described 1, 27 by a multidisciplinary GVHD team including a haematologist, dermatologist, rheumatologist, nurse practitioner and physiotherapist. Only cGVHD patients with deep sclerotic skin changes according to the National Institutes of Health Consensus of 2005 were included. 27 The extent of deep sclerotic skin changes was expressed as percentage of body surface area affected. A diagnosis of SSc was made by an experienced rheumatologist, and all SSc patients fulfilled the American College of Rheumatology criteria for SSc. 28 These patients were subsequently categorised into a limited (LcSSc) and diffuse (DcSSc) cutaneous group, according to LeRoy et al. 29 In SSc patients, the modified Rodnan skin score was used to score the extent of skin involvement. This score consists of an evaluation of patients skin thickness using a 0-3 scale for each of 17 surface anatomic areas of the body (maximum score 51). 30 Healthy controls were recruited through advertisements. Study protocols were approved by the local ethics committee and all participants gave written informed consent according to the Declaration of Helsinki.
Nailfold videocapillaroscopy (NVC)
NVC enables the visualisation of erythrocyte-perfused capillaries in the skin. NVC was performed and computerised mosaic images were obtained as previously described. 14 The combination of high magnification of NVC with the ability to view the whole nailfold (as a mosaic) makes it possible to combine qualitative and quantitative assessments in a reliable way. 26 Both Â 100 (all digits of both hands) and Â 300 (most digits of both hands) magnification mosaic images were available. The investigator was blinded to patient diagnosis; all images were coded and subsequently assessed in random order (randomisation by computer).
Nailfold patterns
Images of all digits were analysed for the presence of enlarged and giant capillaries (see 'Quantitative assessment' section below), avascular areas (loss of capillaries), haemorrhages, distortion of the capillary architecture, and presence of ramified and bushy capillaries. The nailfold capillary pattern most severely affected was scored as normal, abnormal or scleroderma pattern. The scleroderma pattern was divided in an 'early', 'active' and 'late' pattern as described by Cutolo. 31 An 'early' scleroderma pattern is characterised by more than one but fewer than four enlarged capillaries or fewer than four giant capillaries per millimetre, few capillary haemorrhages, relatively well preserved capillary architecture and no evident loss of capillaries. An 'active' scleroderma pattern contains more than six enlarged/giant capillaries, frequent capillary haemorrhages, moderate (20-30%) loss of capillaries and mild disorganisation of the capillary architecture. Finally, a 'late' scleroderma pattern shows irregular enlargement of the capillaries, few or absent giant capillaries and haemorrhages, severe (50-70%) loss of capillaries with large avascular areas, profound disorganisation of the capillary architecture and the presence of ramified/bushy capillaries.
Quantitative assessment
The ring finger of the left hand was quantitatively assessed. Mean apical, arterial, venous and total loop width were based on the measurements of the five capillaries with the largest total loop width. In case of irregular dilated capillary loops, maximal width of each dimension was measured. A widened capillary was defined as having a total loop width of 490 mm, but o150 mm. 32 A giant capillary was defined as having a total loop width of 4150 mm. 32 Capillary density (number of loops per millimetre) was calculated by computer from the manually marked loops in the distal row, where a capillary loop was considered to be a distal loop if the apex of the capillary made an angle of 4901 with the apex of its adjacent capillaries. 26 
Statistical analysis
Numerical data are presented as means and s.d., and Student's t-test was used to analyse the means of two independent categories. Table 1 . Most cGVHD patients had a former diagnosis of AML, and had various conditioning regimens before allografting. In 10 (71%) cGVHD patients 450%, in 3 (21%) 18% and in 1 (7%) 14% of the body surface area was affected by sclerotic skin changes. Mean modified Rodnan score in SSc patients was 10/51 (range 2-24). All SSc patients had Raynaud's phenomenon, in contrast with 3/14 (21%) cGVHD patients and none of the controls. Antinuclear Abs were present in all SSc, and in 1/14 (7%) cGVHD patients, SSc-specific Abs were present in 9/14 SSc patients (64%), but absent in cGVHD patients. The one cGVHD patient that was antinuclear Abs positive, also had Raynaud's phenomenon.
RESULTS

Subject characteristics are shown in
Nailfold patterns All but 1 of the 14 cGVHD patients and all control subjects showed a normal capillary pattern (Figures 1 and 2 ). One cGVHD patient had an abnormal capillary pattern, consisting of the presence of a regularly enlarged capillary in one digit, but without any other abnormalities. This patient had neither Raynaud's phenomenon nor antinuclear Abs, and received a conditioning regime of fludarabine and cyclophosphamide. All 14 SSc patients had a scleroderma pattern; 3 (21%) showed an 'early', 9 (64%) an 'active' and 2 (14%) a 'late' scleroderma pattern.
Quantitative assessment Data on the quantitative assessment are shown in Table 2 . Capillary density (loops/mm) and capillary loop dimensions did not differ between cGVHD and control subjects. In comparison with cGVHD patients, SSc patients had a significantly reduced capillary density and a significant increase in all loop dimensions.
DISCUSSION
This study clearly shows that sclerodermatous cGVHD is not characterised by nailfold capillary abnormalities. A sophisticated imaging technique and reliable assessment methods were used to investigate microcirculatory changes, not only in cGVHD patients, but also in an age-and sex-matched group of SSc patients and healthy controls. Previous NVC studies in patients with sclerodermatous cGVHD showed conflicting results. One study evaluated 10 subjects with sclerodermatous cGVHD, with the examinations routinely carried out in SSc patients (demographic, clinical, serologic and use of imaging techniques). Although no details on imaging technique or assessment method were described, capillaroscopy showed an 'early' scleroderma pattern in one cGVHD patient, and 'nonspecific angiopathy' (mild oedema, mild tortuousity, enlarged capillaries and rare haemorrhages) in two other cGVHD patients. 25 In the same year, another group published their paper on the results of the evaluation of 18 sclerodermatous cGVHD patients and 15 cGVHD patients with lichenoid skin changes. A dermatoscope with a Â 10 magnification was used to evaluate the nailfolds in these patients. Nailfold capillary patterns were abnormal in 15 of the 18 sclerodermatous cGVHD patients, consisting of avascular whitish linear areas at the level of the last row, neovascularisation with reticular pattern, capillary disorganisation, haemorrhages, enlarged capillaries and avascular areas. 24 The authors conclude that these microvascular changes, like in SSc, are a proof of microangiopathy in sclerodermatous cGVHD. Although the studied populations seem rather similar, it is difficult to pinpoint the causes of the different findings in the studies using NVC. The study that reported abnormalities in a high proportion of cGVHD patients 24 used a dermatoscope with a 10-fold magnification to analyse capillary abnormalities, which only allowed for a qualitative analysis. In contrast, we used both 100-and 300-fold digitised panorama mosaic images that enabled us to qualitatively assess the nailfold patterns but also to make precise measurements of capillary loop dimensions and capillary density. Our experience is that even at magnifications of 100-and 300-fold it is often difficult to be certain about definite enlargement of capillaries. Quantitative assessment in those cases is very helpful. Moreover, higher magnifications sometimes demonstrate areas designated as 'avascular' at lower magnifications, not to be devoid of capillaries. Whether these differences in methodology might explain part of the differences remains, however, speculative. Nevertheless, our data have been obtained by using a sophisticated and validated method of NVC resulting in highly reproducible qualitative and quantitative measures. 14, 26 Moreover, the addition of a healthy control group and a group of SSc patients enabled us even to assess subtle changes in capillary morphology and numbers.
Fleming et al. 33 used a different approach by analysing skin biopsies of cGVHD patients with sclerotic skin changes following allo-SCT, SSc patients and controls. They could demonstrate that cGVHD patients, in contrast to SSc patients, did not show an anatomical reduction in vessels compared with control subjects, whereas SSc patients did. Our results add to this by also demonstrating maintenance of the number of functionally perfused capillaries in cGVHD patients comparable to healthy controls.
Although the skin changes in cGVHD may resemble the cutaneous manifestations of SSc, clinical differences exist between the two disorders. Raynaud's phenomenon is almost always present in SSc patients, but, like in this study, in only a minority of sclerodermatous cGVHD patients. 24, 25 Antinuclear Abs may be detected in sclerodermatous cGVHD, but, except for one report, 34 specific SSc-associated Abs, like anti-centromere Abs and antitopoisomerase (Scl-70) Abs are not found in sclerodermatous cGVHD. 24, 25, 35 Dysphagia is a common complaint in cGVHD, but in contrast with SSc patients, no abnormalities could be observed in those cGVHD patients in whom oesophagus manometry was performed. 25 Loss of endothelial-specific markers like vascular endothelial cadherin and von Willebrand factor, as demonstrated in SSc patients, were also not observed in cGVHD patients. 33 To our knowledge, cGVHD following allo-SCT is not associated with other devastating vascular complications of SSc, such as acute renal failure (renal crisis), digital ulcers or primary pulmonary arterial hypertension.
In conclusion, this study shows that nailfold capillary abnormalities are not a hallmark of sclerodermatous cGVHD, making it very unlikely that nailfold capillaroscopy can be used to predict the development of sclerotic skin changes in cGVHD following allo-SCT. Despite the similarities, the pathogenesis of sclerotic skin changes in cGVHD seems not to involve capillary damage. Future research must move on to explore alternative hypotheses for the pathogenesis of sclerodermatous cGVHD.
Normal capillary pattern (X300)
Scleroderma pattern with enlarged capillaries and hemorrhages (X300) Figure 2 . Examples of a normal and scleroderma nailfold pattern. Abbreviations: cGVHD ¼ chronic GVHD; SSc ¼ systemic sclerosis.
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